PTPRC and breast cancer: Given the automated processing and exclusion criteria of the CellSearch® platform, it is likely that larger, naïve heterotypic clusters composed of CTCs complexed with immune cells are rarely presented because of their CD45+/CD34+ or CD45+ cell staining for melanoma and breast cancer samples, respectively.